The treatment of prostate cancer cells with the marine sesterterpenoid, heteronemin, induced mitochondrial dysfunction, oxidative and ER stresses resulting in apoptosis evidenced with annexin V/PI and JC-1 assay. This evidence concerns the gene ANXA5 and prostate cancer.